The Real-World Price of Switching to an ARNI A Case for De Novo Sacubitril/Valsartan Initiation

被引:0
作者
Page Ii, Robert L. [1 ,2 ]
机构
[1] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci Aurora, Dept Clin Pharm, Aurora, CO USA
[2] Univ Colorado, Dept Clin Pharm, Skaggs Sch Pharm & Pharmceut Sci, Mail Stop C238,12850 Easy Mt View Blvd,V20-4125, Aurora, CO 80045 USA
关键词
ACEI; angioedema; ARB; real-world; sacubitril-valsartan; HEART-FAILURE; RANDOMIZED-TRIAL; ENALAPRIL; ANGIOEDEMA; OMAPATRILAT;
D O I
10.1016/j.jacc.2022.11.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:332 / 335
页数:4
相关论文
共 12 条
[1]   Angiotensin II receptor blocker-associated angioedema: On the heels of ACE inhibitor angioedema [J].
Abdi, R ;
Dong, VM ;
Lee, CJ ;
Ntoso, KA .
PHARMACOTHERAPY, 2002, 22 (09) :1173-1175
[2]   The Role of Angiotensin Receptor Blockers in Patients with Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema [J].
Beavers, Craig James ;
Dunn, Steven P. ;
Macaulay, Tracy E. .
ANNALS OF PHARMACOTHERAPY, 2011, 45 (04) :520-524
[3]   Comparative Risk of Angioedema With Sacubitril-Valsartan vs Renin-Angiotensin-Aldosterone Inhibitors [J].
Eworuke, Efe ;
Welch, Emily C. ;
Haug, Nicole ;
Horgan, Casie ;
Lee, Hye Seung ;
Zhao, Yueqin ;
Huang, Ting-Ying .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (04) :321-331
[4]   Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors:: the CHARM-Alternative trial [J].
Granger, CB ;
McMurray, JJV ;
Yusuf, S ;
Held, P ;
Michelson, EL ;
Olofsson, B ;
Östergren, J ;
Pfeffer, MA ;
Swedberg, K .
LANCET, 2003, 362 (9386) :772-776
[5]   2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [J].
Heidenreich, Paul A. ;
Bozkurt, Biykem ;
Aguilar, David ;
Allen, Larry A. ;
Byun, Joni J. ;
Colvin, Monica M. ;
Deswal, Anita ;
Drazner, Mark H. ;
Dunlay, Shannon M. ;
Evers, Linda R. ;
Fang, James C. ;
Fedson, Savitri E. ;
Fonarow, Gregg C. ;
Hayek, Salim S. ;
Hernandez, Adrian F. ;
Khazanie, Prateeti ;
Kittleson, Michelle M. ;
Lee, Christopher S. ;
Link, Mark S. ;
Milano, Carmelo A. ;
Nnacheta, Lorraine C. ;
Sandhu, Alexander T. ;
Stevenson, Lynne Warner ;
Vardeny, Orly ;
Vest, Amanda R. ;
Yancy, Clyde W. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (17) :E253-E421
[6]   Angiotensinogen More Than its Downstream Products: Evidence From Population Studies and Novel Therapeutics [J].
Kahlon, Tanvir ;
Carlisle, Samantha ;
Mostacero, Diana Otero ;
Williams, Nina ;
Trainor, Patrick ;
DeFilippis, Andrew P. .
JACC-HEART FAILURE, 2022, 10 (10) :699-713
[7]   Omapatrilat and enalapril in patients with hypertension: The omapatrilat cardiovascular treatment vs. enalapril (OCTAVE) trial [J].
Kostis, OB ;
Packer, M ;
Black, HR ;
Schmieder, R ;
Henry, D ;
Levy, E .
AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (02) :103-111
[8]   Meta-Analysis of Randomized Trials of Angioedema as an Adverse Event of Renin-Angiotensin System Inhibitors [J].
Makani, Harikrishna ;
Messerli, Franz H. ;
Romero, Jorge ;
Wever-Pinzon, Omar ;
Korniyenko, Aleksander ;
Berrios, Ronaldo Sevilla ;
Bangalore, Sripal .
AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (03) :383-391
[9]   Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure [J].
McMurray, John J. V. ;
Packer, Milton ;
Desai, Akshay S. ;
Gong, Jianjian ;
Lefkowitz, Martin P. ;
Rizkala, Adel R. ;
Rouleau, Jean L. ;
Shi, Victor C. ;
Solomon, Scott D. ;
Swedberg, Karl ;
Zile, Michael R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11) :993-1004
[10]   Comparison of omapatrilat chronic and enalapril in patients with heart failure - The omapatrilat versus enalapril randomized trial of utility in reducing events (OVERTURE) [J].
Packer, M ;
Califf, RM ;
Konstam, MA ;
Krum, H ;
McMurray, JJ ;
Rouleau, JL ;
Swedberg, K .
CIRCULATION, 2002, 106 (08) :920-926